Want to join the conversation?
$ENDP 2Q15 Call: We continue to sharpen our R&D focus on near-term opportunities. We continue to progress towards action date on October 23, 2015 for BELBUCA NDA. Acquisition of Par announced in May create leading specialty pharmaceutical company with top five generics business as measured by US sales with a differentiated portfolio and pipeline.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?